Your browser doesn't support javascript.
loading
Anti-spasticity medications
Saudi Medical Journal. 2003; 24 (1): 19-22
en Inglés | IMEMR | ID: emr-64407
ABSTRACT
Spasticity is common in patients with a variety of central nervous system disorders. It can lead to significant disability or cause complications that may result in severe morbidity. In such patients, treatment of spasticity is warranted. Several oral and parenteral medications are available for use in the treatment of spasticity. This article reviews the pharmacological properties and therapeutic effectiveness of these medications to provide a practical objective guide for physicians who may be involved in the management of spasticity
Asunto(s)
Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Baclofeno / Toxinas Botulínicas / Clonidina / Dantroleno / Diazepam / Ácido gamma-Aminobutírico Idioma: Inglés Revista: Saudi Med. J. Año: 2003

Similares

MEDLINE

...
LILACS

LIS

Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Baclofeno / Toxinas Botulínicas / Clonidina / Dantroleno / Diazepam / Ácido gamma-Aminobutírico Idioma: Inglés Revista: Saudi Med. J. Año: 2003